sorry, one more question from the annual report
did anyone catch that they have a provision for ~1.8m write down of 3.0m of inventory?
Didn't they state after FDA failure that the bulk product had a very long shelf life/stable and expiry only started when bottled/packaged? did they bottle/package a whole bunch of inventory before the first FDA approval submission triggering expiry that they have to now dispose off?
Not that this is incredibly material but I'm still interested in understanding what has happened here
sorry, one more question from the annual report did anyone catch...
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.3¢ |
Change
0.003(0.66%) |
Mkt cap ! $689.3M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 38.5¢ | 37.5¢ | $710.8K | 1.866M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 246385 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.5¢ | 117004 | 4 |
View Market Depth
| Last trade - 12.02pm 27/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |